ArticleCancer immunology, immunotherapy : CII2019

Combination of denosumab and immune checkpoint inhibition: experience in 29 patients with metastatic melanoma and bone metastases.

Yenny Angela et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.